1. Home
  2. STTK vs CARE Comparison

STTK vs CARE Comparison

Compare STTK & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$7.03

Market Cap

569.1M

Sector

Health Care

ML Signal

HOLD

Logo Carter Bankshares Inc.

CARE

Carter Bankshares Inc.

HOLD

Current Price

$25.96

Market Cap

507.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
CARE
Founded
2016
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
569.1M
507.1M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
STTK
CARE
Price
$7.03
$25.96
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$10.00
$25.00
AVG Volume (30 Days)
424.3K
352.2K
Earning Date
05-01-2026
04-23-2026
Dividend Yield
N/A
0.40%
EPS Growth
53.02
30.19
EPS
N/A
1.38
Revenue
$1,000,000.00
$20,315,000.00
Revenue This Year
N/A
$12.50
Revenue Next Year
N/A
$11.82
P/E Ratio
N/A
$18.50
Revenue Growth
N/A
4.65
52 Week Low
$0.71
$15.37
52 Week High
$8.33
$25.65

Technical Indicators

Market Signals
Indicator
STTK
CARE
Relative Strength Index (RSI) 49.99 78.47
Support Level $5.75 $19.34
Resistance Level $7.68 N/A
Average True Range (ATR) 0.52 0.61
MACD -0.13 0.05
Stochastic Oscillator 17.27 91.22

Price Performance

Historical Comparison
STTK
CARE

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

Share on Social Networks: